Study of Treatment Used for Migraine Headaches (MK-0974-076)
NCT01421277 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 216
Last updated 2017-06-20
Summary
This study will describe the reasons for triptan utilization patterns (continuation and discontinuation) in triptan-naïve participants and assess the stability of treatment utilization patterns over time according to standard medical guidelines or clinical practice standards of the investigating physician.
Conditions
Interventions
- DRUG
-
Statin Therapy
Investigator's choice of any statin.
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-19
- Primary Completion
- 2012-03-23
- Completion
- 2012-03-23
More Related Trials
-
Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine
NCT01905748 ·Status: UNKNOWN ·Phase: NA
-
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
NCT00758836 ·Status: COMPLETED ·Phase: PHASE2
-
A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
NCT00821483 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)
NCT01513291 ·Status: COMPLETED ·Phase: PHASE2
-
Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)
NCT00443209 ·Status: COMPLETED ·Phase: PHASE3
-
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692 ·Status: WITHDRAWN
-
MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
NCT00797667 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
NCT00253175 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)
NCT00483704 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
NCT01613248 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
NCT00231595 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
NCT00442936 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine
NCT05843721 ·Status: TERMINATED ·Phase: NA
-
Thrombophilia and Migraine, Are They Related?
NCT00457184 ·Status: COMPLETED
-
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
NCT01044251 ·Status: COMPLETED ·Phase: PHASE2
-
Standardized sTudy With Almotriptan in eaRly Treatment of Migraine
NCT00725140 ·Status: COMPLETED
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
NCT00095004 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches
NCT00210912 ·Status: COMPLETED ·Phase: PHASE3
-
Detoxification and Treatment of Subjects With Medication Overuse Headache
NCT00432549 ·Status: UNKNOWN ·Phase: PHASE4
-
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
NCT01435941 ·Status: COMPLETED
-
An Open Label Extension of a Study of Topiramate in Chronic Migraine.
NCT00210873 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)
NCT01209741 ·Status: COMPLETED ·Phase: PHASE1